{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:42:01Z","timestamp":1774327321726,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NanoAthero","award":["FP7-NMP-2012-LARGE-6-309820"],"award-info":[{"award-number":["FP7-NMP-2012-LARGE-6-309820"]}]},{"name":"Nanomile","award":["NMP4-LA-2013-310451"],"award-info":[{"award-number":["NMP4-LA-2013-310451"]}]},{"name":"University of Miskolc"},{"DOI":"10.13039\/501100001381","name":"National Research Foundation of Singapore","doi-asserted-by":"publisher","award":["NRF-CRP10-2012-07"],"award-info":[{"award-number":["NRF-CRP10-2012-07"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["KNRF\/2-1605-0017"],"award-info":[{"award-number":["KNRF\/2-1605-0017"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jconrel.2017.11.043","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T09:48:08Z","timestamp":1512208088000},"page":"268-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information"],"prefix":"10.1016","volume":"270","author":[{"given":"Tam\u00e1s","family":"F\u00fcl\u00f6p","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9ka","family":"Nemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"M\u00e9sz\u00e1ros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Urbanics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbert Jan","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Jackman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Joon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Szebeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.11.043_bb0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2014.08.002","article-title":"Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications","volume":"18","author":"Jin","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/nbm.3293","article-title":"Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: imaging optimization and feasibility test","volume":"28","author":"Kwon","year":"2015","journal-title":"NMR Biomed."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.colsurfb.2014.11.045","article-title":"Exploring a new SPION-based MRI contrast agent with excellent water-dispersibility, high specificity to cancer cells and strong MR imaging efficacy","volume":"126","author":"Ma","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/wnan.1400","article-title":"Functional nanoparticles for magnetic resonance imaging","volume":"8","author":"Mao","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1039\/C6BM00621C","article-title":"Highly versatile SPION encapsulated PLGA nanoparticles as photothermal ablators of cancer cells and as multimodal imaging agents","volume":"5","author":"Sivakumar","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.phrs.2009.12.012","article-title":"From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications","volume":"62","author":"Figuerola","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0035","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.2147\/IJN.S30320","article-title":"Arora, Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers","volume":"7","author":"Wahajuddin","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/17425247.2013.747507","article-title":"Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics","volume":"10","author":"Mok","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbrc.2015.06.177","article-title":"Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs","volume":"468","author":"Szebeni","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0060","series-title":"Handbook of Immunological Properties of Engineered Nanomaterials","first-page":"331","article-title":"Case study: Complement activation related hypersensitivity reactions to PEGylated liposomal doxorubicin: Experimental and clinical evidence, mechanisms and approaches to inhibition","author":"Szebeni","year":"2015"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0065","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.nano.2015.12.377","article-title":"Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model","volume":"12","author":"Jackman","year":"2016","journal-title":"Nanomedicine: NBM"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0070","author":"W. Bayer Healthcare Pharmaceuticals, NJ"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0080","series-title":"Oncology, Drug Advisory Committee Biefing Doument, NDA 21-115","first-page":"68","author":"C. Advanced Magnetics Inc.","year":"2005"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/1522-2586(200008)12:2<205::AID-JMRI1>3.0.CO;2-P","article-title":"Safety of approved MR contrast media for intravenous injection","volume":"12","author":"Runge","year":"2000","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00002142-200108000-00007","article-title":"Safety of magnetic resonance contrast media","volume":"12","author":"Runge","year":"2001","journal-title":"Top. Magn. Reson. Imaging"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0095","first-page":"151","article-title":"In vitro and in vivo differences in murine third complement component (C3) opsonization and macrophage\/leukocyte responses to antibody-functionalized iron oxide nanoworms","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nnano.2016.269","article-title":"Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo","volume":"12","author":"Chen","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0105","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.1021\/acsnano.5b05061","article-title":"Modulatory role of surface coating of superparamagnetic iron oxide nanoworms in complement opsonization and leukocyte uptake","volume":"9","author":"Inturi","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12989-014-0064-2","article-title":"Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum","volume":"11","author":"Banda","year":"2014","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0115","doi-asserted-by":"crossref","first-page":"12437","DOI":"10.1021\/nn505126b","article-title":"High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties","volume":"8","author":"Wang","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000451060","article-title":"Distinct in vitro complement activation by various intravenous iron preparations","volume":"45","author":"Hempel","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000451069","article-title":"Complement activation-related pseudo-allergy: a fresh look at hypersensitivity reactions to intravenous iron","volume":"45","author":"Macdougall","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0130","series-title":"Poly(amino acid)s: Next-generation Coatings for Long-circulating Liposomes","article-title":"Initial observations on complement activation by poly(amino acid)-coated liposomes","author":"Romberg","year":"2007"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2013.03.007","article-title":"Complement activation by PEGylated liposomes containing prednisolone","author":"van den Hoven","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1515\/ejnm-2015-0022","article-title":"Paradoxical rise of hemolytic complement in the blood of mice during zymosan- and liposome induced CARPA: a pilot study","volume":"7","author":"M\u00e9sz\u00e1ros","year":"2015","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0145","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.addr.2012.07.005","article-title":"A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines","volume":"64","author":"Szebeni","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jconrel.2012.02.029","article-title":"Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model","volume":"160","author":"Szebeni","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1515\/ejnm-2015-0011","article-title":"Lessons learned from the porcine CARPA model: constant and variable responses to different nanomedicines and administration protocols","volume":"7","author":"Urbanics","year":"2015","journal-title":"Eur J. Nanomed."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nnano.2017.47","article-title":"Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes","volume":"12","author":"Wibroe","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/90.4.300","article-title":"Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study","volume":"90","author":"Szebeni","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/08982100009031112","article-title":"The role of complement activation in hypersensitivity to pegylated liposomal doxorubicin (Doxil\u00ae)","volume":"10","author":"Szebeni","year":"2000","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0175","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1567-5769(01)00006-6","article-title":"Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions","volume":"1","author":"Szebeni","year":"2001","journal-title":"Intern. Immunopharm."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1081\/LPR-120004790","article-title":"Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies","volume":"12","author":"Szebeni","year":"2002","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0185","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijpharm.2006.11.018","article-title":"Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes","volume":"331","author":"Romberg","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejps.2013.03.007","article-title":"Complement activation by PEGylated liposomes containing prednisolone","volume":"49","author":"van den Hoven","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1515\/ejnm-2015-0026","article-title":"Variable association of complement activation by rituximab and paclitaxel in cancer patients in vivo and in their screening serum in vitro with clinical manifestations of hypersensitivity: a pilot study","volume":"7","author":"Kozma","year":"2015","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0205","doi-asserted-by":"crossref","first-page":"e57335","DOI":"10.1371\/journal.pone.0057335","article-title":"Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging","volume":"8","author":"Starmans","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0730-725X(95)00024-B","article-title":"Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil","volume":"13","author":"Jung","year":"1995","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0215","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","article-title":"Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates","volume":"27","author":"Filipe","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0220","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.chemphyslip.2011.11.012","article-title":"Flow cytometric analysis of supravesicular structures in doxorubicin-containing pegylated liposomes","volume":"165","author":"Milosevits","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jconrel.2017.11.043_bb0225","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.0804031","article-title":"The binding of Factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome","volume":"182","author":"Ferreira","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0230","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/mrm.1910290504","article-title":"Monocrystalline iron oxide nanocompounds (MION): physicochemical properties","volume":"29","author":"Shen","year":"1993","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0235","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1056\/NEJMoa022749","article-title":"Noninvasive detection of clinically occult lymph-node metastases in prostate cancer","volume":"348","author":"Harisinghani","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.11.043_bb0240","author":"FDA"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T16:48:50Z","timestamp":1589820530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917310507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":47,"alternative-id":["S0168365917310507"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}